Cost-effectiveness and total costs of three alternative strategies for the prevention and management of severe skin reactions attributable to thiacetazone in the treatment of human immunodeficiency virus positive patients with tuberculosis in Kenya-Reference-Cited by-同舟云学术

Cost-effectiveness and total costs of three alternative strategies for the prevention and management of severe skin reactions attributable to thiacetazone in the treatment of human immunodeficiency virus positive patients with tuberculosis in Kenya

Published:1996-02 Issue:1 Volume:77 Page:30-36
ISSN:0962-8479
Container-title:Tubercle and Lung Disease
language:en
Short-container-title:Tubercle and Lung Disease

Author:

van Gorkom J.,Kibuga D.K.

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Immunology,Microbiology

Reference15 articles.

1. HIV-associated tuberculosis in developing countries: epidemiology and strategies for prevention;Narain;Tubercle Lung Dis,1992

2. Tuberculosis and AIDS, Statement on AIDS and tuberculosis;Global Programme on AIDS and Tuberculosis Programme WHO;Bull Int Union Tuberc Lung Dis,1989

3. Tuberculosis in developing countries: burden, intervention and cost;Murray;Bull Int Union Tuberc Lung Dis,1990

4. Cohort study of Human Immunodeficiency Virus Infection in Patients with Tuberculosis in Nairobi, Kenya;Nunn;Am Rev Respir Dis,1992

5. HIV-associated tuberculosis in the developing countries: clinical features, diagnosis and treatment;Raviglione;Bull WHO,1992

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The cost to health services of human immunodeficiency virus (HIV) co-infection among tuberculosis patients in Sudan;Health Policy;2006-02

2. Costs and effectiveness—the impact of economic studies on TB control;Tuberculosis;2003-02

3. Economic evaluation of communicable disease interventions in developing countries: a critical review of the published literature;Health Economics;2000

4. Evaluation of the drug treatment regimens for pulmonary tuberculosis and their cost-effectiveness;Expert Opinion on Pharmacotherapy;1999-11

5. ECONOMIC EVALUATION OF DIAGNOSTIC TESTS;International Journal of Technology Assessment in Health Care;1999-07